Invivyd was granted an Emergency Use Authorization by the United States FDA for PEMGARDA, a pre-exposure prophylaxis (PrEP) treatment for COVID-19. The administration is authorizing the therapy for...
A study published in JAMA on March 25, 2024, found racial and gender disparities in donor heart acceptances by transplant center teams, noting that Black men on the wait list were the least likely to...
An analysis of global fertility in 204 countries and territories between 1950 and 2021 was published in the Lancet on March 20, 2024, revealing that global fertility rates are declining, with some...
The CDC is urging healthcare providers to recommend and administer measles vaccines for patients six months and older in a recent Health Alert Network (HAN) Health advisory. In light of recent measles...
An estimated 3.40 billion individuals are impacted by 37 nervous system conditions worldwide, noted researchers in a study published in the Lancet Neurology. Collectively, the 37 conditions were the...
Research suggests that the rising rates of maternal mortality in the United States may represent changes in maternal mortality surveillance instead of an increase in incidence. While data from the...
On March 12, 2024, the NIH announced that it would open another clinical trial on long COVID, evaluating treatment options for COVID-induced autonomic nervous system dysfunction, as part of the...
On March 11, 2024, the Canadian Medical Association Journal published an article evaluating longitudinal adherence to surveillance for childhood cancer survivors, highlighting that many survivors did...
Recently, JAMA Network Open published a study analyzing the association between a healthy diet, sleep duration, and type 2 diabetes (T2D) risk. The study data revealed that habitual short sleep...
In a press announcement published on March 6, 2024, the United States Attorney’s Office of the Southern District of New York revealed that Laura Perryman, founder and former CEO of Stimwave, was...
On Tuesday, March 5, 2024, the United States FDA cleared the first over-the-counter continuous glucose monitor (CGM), the Dexcom Stelo Glucose Biosensor System. This new approval marks the first time...
On Friday, March 1, 2024, the United States Centers for Disease Control and Prevention (CDC) issued a press release revealing that it no longer recommends that individuals with COVID-19 isolate for...
On Wednesday, February 28, 2024, the Journal of the American Heart Association (JAHA) published a study linking cannabis use to adverse cardiovascular outcomes, including heart attack and stroke. This...
On February 28, 2023, JAMA Network Open published survey results revealing that an alternate internal medicine resident training schedule was linked to reducing burnout and self-reported professional,...
Prenatal mental health interventions reduced the risk of moderate-to-severe postpartum anxiety by two-thirds in an NIH-funded study based in the Punjab Province of Pakistan. According to an NIH press...
On Tuesday, February 20, 2024, the American Academy of Pediatrics (AAP) journal, Pediatrics, published a study characterizing factors in sudden unexpected infant deaths (SUID), which is sometimes...
Last week, researchers from the National Institutes of Health (NIH) All of Us Research Program published an article in Nature identifying over 275 million new genetic variants across approximately...
On February 16, 2024, the Alabama Supreme Court issued a ruling that characterized frozen embryos as people, indicating that any destruction of these frozen embryos could be considered a crime. Despite...
On February 13, 2024, eGenesis, a United States-based biotechnology company, and PorMedTec, a Japanese porcine embryology organization, announced positive results of their collaboration, which produced...
On Monday, February 12, 2024, First Street Foundation, a nonprofit focused on quantifying and relaying the risks of climate change globally, released a report outlining the impacts of climate change on...
